Healthcare AI investors focused on Pharma / Therapeutics
Venture firms, family offices, accelerators, and corporate VCs with explicit thesis exposure to Pharma / Therapeutics within healthcare AI. Includes lead investors, follow-on participants, and active angels.
The therapeutics sector focuses on the scientific research, clinical development, and commercialization of chemical or biological compounds used to treat diseases. Venture investment in this space is heavily milestone-driven, guiding novel drugs from early pre-clinical laboratory research through rigorous, multi-phase human clinical trials to ultimate regulatory approval.
339
investors match
Within Pharma / Therapeutics: top investment stages
NeuroVentures
VC
T3
Biotech
Pharma / Therapeutics
New Age Ventures
VC
T3
Biotech
Digital Health
New Enterprise Associates (NEA)
VC
T1
AI/ML in Healthcare
Biotech
New Harbor Venture Partners
VC
T3
Biotech
Digital Health
New Leaf Venture Partners
VC
T3
Biotech
Diagnostics
Next Frontier Capital
VC
T3
AI/ML in Healthcare
Biotech
NFX
VC
T3
AI/ML in Healthcare
Biotech
Noetic Fund
VC
T3
Biotech
Digital Health
Nordic Capital
PE
T3
Care Delivery / Tech-Enabled Services
Pharma / Therapeutics
Northern Gritstone
VC
T3
Biotech
Diagnostics
Northstar Group
PE
T2
Care Delivery / Tech-Enabled Services
Pharma / Therapeutics
Northventures.dk
VC
T3
AI/ML in Healthcare
Biotech
Novartis Venture Fund
Corporate VC
T1
Biotech
Pharma / Therapeutics
Novaterra
VC
T3
Biotech
Digital Health
NVentures
Corporate VC
AI
T3
AI/ML in Healthcare
Biotech